2016

Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups
Thomas C, Sill M, Ruland V, Witten A, Hartung S, Kordes U, Jeibmann A, Beschorner R, Keyvani K, Bergmann M, Mittelbronn M, Pietsch T, Felsberg J, Monoranu C, Varlet P, Hauser P, Olar A, Grundy R, Wolff J, Korshunov A, Jones D, Bewerunge-Hudler M, Hovestadt V, von Deimling A, Pfister S, Paulus W, Capper D, Hasselblatt M
NEURO-ONCOLOGY. 2016;18(6):790-6.

2015

High-resolution genomic analysis does not qualify atypical plexus papilloma as a separate entity among choroid plexus tumors
Japp A, Gessi M, Messing-Jünger M, Denkhaus D, Zur Mühlen A, Wolff J, Hartung S, Kordes U, Klein-Hitpass L, Pietsch T
J NEUROPATH EXP NEUR. 2015;74(2):110-20.

Pediatric atypical choroid plexus papilloma reconsidered: increased mitotic activity is prognostic only in older children
Thomas C, Ruland V, Kordes U, Hartung S, Capper D, Pietsch T, Gerß J, Wolff J, Paulus W, Hasselblatt M
ACTA NEUROPATHOL. 2015;129(6):925-7.

2014

Choroid plexus carcinomas are characterized by complex chromosomal alterations related to patient age and prognosis
Ruland V, Hartung S, Kordes U, Wolff J, Paulus W, Hasselblatt M
GENE CHROMOSOME CANC. 2014;53(5):373-80.

Methylation of the hTERT promoter is frequent in choroid plexus tumors but not of independent prognostic value
Ruland V, Hartung S, Kordes U, Wolff J, Paulus W, Hasselblatt M
J NEURO-ONCOL. 2014;119(1):215-6.

2012

CPT SIOP
Wolff J, Hasselblatt M, Hartung S, Powell M, Garami M, Traunecker H, Thall P, Mahajan A, Kordes U, Sumerauer D
J NEURO-ONCOL. 2012;14:i153.

2007

Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism
Bay K, Virtanen H, Hartung S, Ivell R, Main K, Skakkebaek N, Andersson A, Toppari J
J CLIN ENDOCR METAB. 2007;92(10):4020-7.

2006

Cellular origins of testicular dysgenesis in rats exposed in utero to di(n-butyl) phthalate
Mahood I, McKinnell C, Walker M, Hallmark N, Scott H, Fisher J, Rivas A, Hartung S, Ivell R, Mason J, Sharpe R
INT J ANDROL. 2006;29(1):148-54; discussion 181-5.

2005

Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis
Bay K, Hartung S, Ivell R, Schumacher M, Jürgensen D, Jorgensen N, Holm M, Skakkebaek N, Andersson A
J CLIN ENDOCR METAB. 2005;90(6):3410-8.

Development and function of the adult generation of Leydig cells in mice with Sertoli cell-selective or total ablation of the androgen receptor
De Gendt K, Atanassova N, Tan K, de França L, Parreira G, McKinnell C, Sharpe R, Saunders P, Mason J, Hartung S, Ivell R, Denolet E, Verhoeven G
ENDOCRINOLOGY. 2005;146(9):4117-26.

Insulin-like factor 3 - where are we now?
Ivell R, Hartung S, Anand-Ivell R
ANN NY ACAD SCI. 2005;1041:486-96.

Expression of insulin-like factor 3 protein in the rat testis during fetal and postnatal development and in relation to cryptorchidism induced by in utero exposure to di (n-Butyl) phthalate
McKinnell C, Sharpe R, Mahood K, Hallmark N, Scott H, Ivell R, Staub C, Jégou B, Haag F, Koch-Nolte F, Hartung S
ENDOCRINOLOGY. 2005;146(10):4536-44.

2003

The molecular basis of cryptorchidism
Ivell R, Hartung S
MOL HUM REPROD. 2003;9(4):175-81.

Letzte Aktualisierung aus dem FIS: 25.04.2024 - 00:49 Uhr